FIELD: medicine.
SUBSTANCE: chemiluminescence analysis is used to assess functional activity of white blood cells. Additionally, the parameters of chemiluminescence kinetics induced by a suspension of a clinical strain of methicillin-resistant Staphylococcus aureus, and if the curve peaking time values ranging within 2287 to 3520 seconds, the maximum signal intensity ranging within 4257 to 9516 standard units, while the light sum value is within 169000 to 362000 standard units, a normal functional ability of phagocytes is stated, while the different values enables recording a disturbed functional ability of phagocytes.
EFFECT: use of the declared method enables higher sensitivity for assessing the functional ability of phagocytes and higher specificity for detecting phagocyte dysfunction.
1 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF DEVELOPING SUPPURATIVE COMPLICATIONS OF ACUTE PANCREATITIS | 2011 |
|
RU2454671C1 |
| METHOD OF MEASURING STIMULATING EFFECT OF IMMUNOGLOBULINE PREPARATIONS FOR INTRAVENOUS INJECTION ONTO PROTECTIVE ACTIVITY OF PHAGOCITES | 2006 |
|
RU2318202C1 |
| METHOD FOR VERIFICATION OF INFECTED PANCREATONECROSIS | 2018 |
|
RU2701493C1 |
| DIAGNOSING OF CLINICAL COURSE OF PANCREATONECROSIS | 2011 |
|
RU2463601C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF BACTERIAL RHINOSINUSITIS INFLAMMATION FORMS | 2020 |
|
RU2741211C1 |
| METHOD FOR DETERMINING THE ACTIVITY OF RECEPTORS OF HUMAN NEUTROPHILS | 0 |
|
SU1686372A1 |
| COMPOSITIONS COMPRISING COCKTAILS OF ANTIBACTERIAL PHAGES AND USES THEREOF | 2013 |
|
RU2654596C2 |
| METHOD FOR PREDICTING INFECTED PANCREONECROSIS | 2006 |
|
RU2319150C1 |
| ANTIBACTERIAL COMPOSITION FOR PREVENTION OR TREATMENT OF HOSPITAL INFECTIONS (VERSIONS), BACTERIOPHAGE STAMPS USED TO OBTAIN SUCH COMPOSITION | 2015 |
|
RU2628312C2 |
| METHOD FOR DIAGNOSIS FOR IN VITRO OF SPECIFIC BODY SENSITISATION TO BACTERIAL ALLERGENS | 2014 |
|
RU2587327C2 |
